Impedance spectroscopy assisted by magnetic nanoparticles as a potential biosensor principle for breast cancer cells in suspension

Breast cancer (BC) is the leading cause of cancer death in women worldwide, with a higher mortality reported in undeveloped countries. Ideal adjuvant therapeutic strategies require the continuous monitoring of patients by regular blood tests to detect circulating cancer cells, in order to determine...

Full description

Saved in:
Bibliographic Details
Published inPhysiological measurement Vol. 35; no. 6; pp. 931 - 941
Main Authors Silva, Jesús G, Cárdenas, Rey A, Quiróz, Alan R, Sánchez, Virginia, Lozano, Lucila M, Pérez, Nadia M, López, Jaime, Villanueva, Cleva, González, César A
Format Journal Article
LanguageEnglish
Published England IOP Publishing 01.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Breast cancer (BC) is the leading cause of cancer death in women worldwide, with a higher mortality reported in undeveloped countries. Ideal adjuvant therapeutic strategies require the continuous monitoring of patients by regular blood tests to detect circulating cancer cells, in order to determine whether additional treatment is necessary to prevent cancer dissemination. This circumstance requires a non-complex design of tumor cell biosensor in whole blood with feasibility for use in poor regions. In this work we have evaluated an inexpensive and simple technique of relative bioimpedance measurement, assisted by magnetic nanoparticles, as a potential biosensor of BC cells in suspension. Measurements represent the relative impedance changes caused by the magnetic holding of an interphase of tumor cells versus a homogenous condition in the frequency range of 10-100 kHz. The results indicate that use of a magnet to separate tumor cells in suspension, coupled to magnetic nanoparticles, is a feasible technique to fix an interphase of tumor cells in close proximity to gold electrodes. Relative impedance changes were shown to have potential value as a biosensor method for BC cells in whole blood, at frequencies around 20 kHz. Additional studies are warranted with respect to electrode design and sensitivity at micro-scale levels, according to the proposed technique.
Bibliography:Institute of Physics and Engineering in Medicine
PMEA-100072.R2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0967-3334
1361-6579
DOI:10.1088/0967-3334/35/6/931